Original Article

Preexposure Prophylaxis for HIV Prevention in a Rural Southern Clinic

Authors: Robin L. Harrison, MD, Ciarra Dortche, MPH, Nada Fadul, MD

Abstract

Objectives: Little is known about implementing preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) in the rural US South, where most HIV infections occur. To investigate how to better reach the at-risk population in rural eastern North Carolina (ENC), the characteristics and clinical courses of those receiving PrEP from our clinic were reviewed and analyzed.

Methods: A retrospective study was used to describe the characteristics and outcomes of PrEP participants in rural ENC.

Results: Thirty-five patients were included whose median age was 37 years (range 22–69). The majority of patients tolerated PrEP well and continued the medication, with only 6 (17%) discontinuations; the reasons for discontinuing included partner mistrust, intolerance to medication, and pregnancy. Patients who initiated PrEP in ENC were more likely to be insured (89%), White (66%), and male (69%). Average travel time to the clinic was 34 minutes (range 2–123 minutes) and the average travel distance was 23 mi (range 1–93 mi).

Conclusions: The study results were noteworthy given that in North Carolina, young Black men have the highest estimated rates of HIV infection. The reasons behind this discrepancy are likely multifactorial, and this study highlights the need for future programs and research to make PrEP more widely accessible to the at-risk population in this rural ENC community.
Posted in: Infectious Disease146 Acquired Immunodeficiency Syndrome (AIDS) And Human Immunodeficiency Virus (HIV) Infection21

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2015–2019: HIV Surveillance Supplemental Report 26 (1). https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-26-1.pdf. Published May 2021. Accessed October 6, 2021.
 
2. Centers for Disease Control and Prevention. HIV surveillance report, 2010. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2010. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2010-vol-22.pdf. Published March 2012. Accessed October 6, 2021.
 
3. Centers for Disease Control and Prevention. HIV in the United States and dependent areas. https://www.cdc.gov/hiv/statistics/overview/ataglance.html Published August 9, 2021. Accessed October 6, 2021.
 
4. Centers for Disease Control and Prevention. 2016 Conference on Retroviruses and Opportunistic Infections. https://www.cdc.gov/nchhstp/newsroom/2016/croi-2016.html#Graphics2. Published December 7, 2018. Accessed October 6, 2021.
 
5. Centers for Disease Control and Prevention. Issue brief: HIV in the southern United States. https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf. Published September 2019. Accessed October 6, 2021.
 
6. Centers for Disease Control and Prevention. HIV surveillance report, 2019. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-32/index.html. Published May 2021. Accessed October 6, 2021.
 
7. Centers for Disease Control and Prevention. Statistics overview. https://www.cdc.gov/hiv/statistics/overview/index.html. Published June 24, 2021. Accessed October 6, 2021.
 
8. Centers for Disease Control and Prevention. 2016 CROI press release: lifetime HIV risk. https://www.cdc.gov/nchhstp/newsroom/2016/croi-press-release-risk.html. Published December 7, 2018. Accessed October 6, 2021.
 
9. North Carolina Department of Health and Human Services. NC DPH: HIV/STD facts & figures: North Carolina HIV/AIDS, STDs, and viral hepatitis B and C. https://epi.dph.ncdhhs.gov/cd/stds/figures.html. Accessed October 6, 2021.
 
10. Centers for Disease Control and Prevention. New guidelines recommend daily HIV prevention pill for those at substantial risk. https://www.cdc.gov/nchhstp/dear_colleague/2014/dcl-051414-hiv-prep.html. Published May 2014. Accessed April 4, 2017.
 
11. Centers for Disease Control and Prevention: United States Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update. A clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Published 2014. Accessed September 18, 2022.
 
12. Centers for Disease Control and Prevention. HIV in the United States by region. https://www.cdc.gov/hiv/statistics/overview/geographicdistribution.html. Accessed April 4, 2018.
 
13. Centers for Disease Control and Prevention. Daily pill can prevent HIV: reaching people who could benefit from PrEP. https://www.cdc.gov/vitalsigns/hivprep/index.html. Published November 24, 2015. Accessed April 4, 2017.
 
14. North Carolina HIV/STD/Hepatitis Surveillance Unit. 2019 North Carolina HIV surveillance report. https://epi.dph.ncdhhs.gov/cd/stds/figures/hiv19rpt_11302020.pdf. Published 2020. Accessed October 6, 2021.
 
15. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. HIV prevention pill not reaching most Americans who could benefit—especially people of color. https://www.hiv.gov/blog/hiv-prevention-pill-not-reaching-most-americans-who-could-benefit-especially-people-color. Published March 6, 2018. Accessed December 28, 2018.
 
16. Braveman PA, Egerter SA, Mockenhaupt RE. Broadening the focus: the need to address the social determinants of health. Am J Prevent Med 2011: 40(suppl 1):S4–S18.
 
17. North Carolina Department of Health and Human Services. NC opioid action plan data dashboard. https://www.ncdhhs.gov/opioid-and-substance-use-action-plan-data-dashboard. Accessed March 14, 2019.
 
18. Allen ST, O’Rourke A, White RH, et al. Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: a qualitative study. AIDS Behav 2020;24:1942–1950.
 
19. NC Department of Health and Human Services. North Carolina health professional shortage area: 2019 profile. https://files.nc.gov/ncdhhs/2019%20NC%20DHHS%20ORH%20HPSA%20One%20Pager.pdf. Published January 1, 2019. Accessed October 6, 2021.
 
20. Doblecki-Lewis S, Liu A, Feaster D, et al. Healthcare access and PrEP continuation in San Francisco and Miami after the US PrEP Demo Project. J Acquir Immune Defic Syndr 2017;74:531–538.
 
21. US Census Bureau. QuickFacts: North Carolina. Persons in poverty, percent. https://www.census.gov/quickfacts/fact/map/NC/IPE120221. Accessed September 13, 2021.
 
22. Harris LR, Khachaturyan S, Dreier A. U.S. Census Bureau releases data on health insurance coverage in N.C. https://www.ncjustice.org/u-s-census-bureau-releases-data-on-health-insurance-coverage-in-n-c/. Published September 15, 2020. Accessed October 6, 2021.
 
23. Siegler AJ, Bratcher A, Weiss KM. Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States. Am J Public Health 2019;109:1216–1223.